Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Pre-transplant cellular alloreactivity is predictive of acute graft rejection and one-year graft function in kidney transplant recipients

K Kościelska-Kasprzak, D Drulis-Fajdasz, D Kamińska, O Mazanowska, M Krajewska, W Bieniecki, P Chudoba, W Polak, D Jańczak, D Patrzałek, M Klinger

Ann Transplant 2009; 14(1): 22-22 :: ID: 880278


In our study we investigated the cellular alloimmunity of kidney allograft recipients using direct interferon (IFN)-g enzyme-linked immunospot assay (ELISPOT). Donor splenocytes PBMC of 53 recipients were obtained alongside kidney recovery. 11 recipients presented positive pre-transplant PRA values. For ELISPOT data analysis we calculated number, size and intensity of the spots, which reflected the volume of cytokine secretion at the single cell level. The results were recalculated as the ratios of the values observed for donor stimulated and unstimulated recipient cells and corrected for residual donor activity. Significantly higher pre-transplant donor stimulated activity was observed for the recipients who underwent AR episode within one year after Tx (p<0.05). The mean change in the spot number, size and intensity observed for rejectors vs. nonrejectors were 0.99 vs. 3.33, 1.6 vs. 6.05, and 1.4 vs. 6.31, respectively. The assessed parameters were prognostic of high AR risk - 1.5-fold increase in spot number (AR incidence 9% vs. 52%), 2.0-fold increase in size (AR incidence 11% vs. 44%), and 2.7-fold increase in intensity (AR incidence 9% vs. 52%). The three parameters analyzed were correlated with the one year serum creatinine concentration (p<0.05). From 14 AR positive recipients, 11 could have been predicted with pre-transplant ELISPOT measures, while only 2 based upon PRA values. Our data show that the ELISPOT determined volume of donor induced activity observed for the recipient cells obtained just before Tx is predictive of the risk of graft rejection and one-year term graft function.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358